QIAGEN NV (QGEN)
42.90
+0.42
(+0.99%)
USD |
NYSE |
Sep 16, 16:00
42.92
+0.02
(+0.03%)
After-Hours: 20:00
QIAGEN Net Income (Quarterly) : 103.40M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 103.40M |
| March 31, 2026 | 68.04M |
| December 31, 2025 | 107.83M |
| September 30, 2025 | 130.04M |
| June 30, 2025 | 96.25M |
| March 31, 2025 | 90.76M |
| December 31, 2024 | 88.32M |
| September 30, 2024 | 98.06M |
| June 30, 2024 | -183.46M |
| March 31, 2024 | 80.67M |
| December 31, 2023 | 97.66M |
| September 30, 2023 | 77.82M |
| June 30, 2023 | 80.79M |
| March 31, 2023 | 85.04M |
| December 31, 2022 | 88.84M |
| September 30, 2022 | 82.39M |
| June 30, 2022 | 96.66M |
| March 31, 2022 | 155.31M |
| December 31, 2021 | 129.19M |
| September 30, 2021 | 133.14M |
| June 30, 2021 | 121.05M |
| March 31, 2021 | 129.22M |
| December 31, 2020 | 212.68M |
| September 30, 2020 | 16.91M |
| June 30, 2020 | 89.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.83M |
| December 31, 2019 | 44.93M |
| September 30, 2019 | -160.64M |
| June 30, 2019 | 44.73M |
| March 31, 2019 | 29.52M |
| December 31, 2018 | 60.95M |
| September 30, 2018 | 60.32M |
| June 30, 2018 | 36.82M |
| March 31, 2018 | 32.30M |
| December 31, 2017 | -39.69M |
| September 30, 2017 | 48.48M |
| June 30, 2017 | 13.95M |
| March 31, 2017 | 17.65M |
| December 31, 2016 | 8.623M |
| September 30, 2016 | 33.71M |
| June 30, 2016 | 21.27M |
| March 31, 2016 | 15.66M |
| December 31, 2015 | 48.37M |
| September 30, 2015 | 34.01M |
| June 30, 2015 | 25.11M |
| March 31, 2015 | 19.36M |
| December 31, 2014 | 26.05M |
| September 30, 2014 | 34.81M |
| June 30, 2014 | 33.06M |
| March 31, 2014 | 23.28M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Illumina, Inc. | 207.00M |
| Thermo Fisher Scientific, Inc. | 1.742B |
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 371.40M |
| Waters Corp. | -136.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 535.04M |
| Total Expenses (Quarterly) | 431.64M |
| EPS Diluted (Quarterly) | 0.4975 |
| Enterprise Value | 9.709B |
| Gross Profit Margin (Quarterly) | 63.17% |
| Profit Margin (Quarterly) | 19.33% |
| Earnings Yield | 4.59% |
| Operating Earnings Yield | 5.80% |
| Normalized Earnings Yield | 5.178 |